DNDi needs for future registration of new treatments in Africa.

From:
Department for International Development
Published
1 January 2009
Document Type:
Conference Paper
Theme:
Health
Authors:
Torreele, E., Balasegaram, M.

Abstract

This presentation describes the issues of registration of fexinidazole for human African trypanosomiasis and of paromomycin for visceral leishmaniasis in Africa, with a mention of how nifurtimox-eflornithine combination therapy for the latter disease was dealt with.

Citation

Presentation from DNDi’s Regulatory Workshop - Nairobi, Kenya, 24 June 2009.

DNDi needs for future registration of new treatments in Africa.

Published 1 January 2009
Contents